| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Jasper Therapeutics, Inc. (JSPR) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 8 sells. JSPR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 234.0K | $215.3K | - | |
| Dir | 156.9K | $144.4K | - | |
| COO | 90.0K | $82.8K | - | |
| CFO | 90.0K | $82.8K | - | |
| Other | 90.0K | $82.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 21, 2020 | Glazer Capital, LLC69 | 10% Owner | Sell | 1,000 | $10.00 | $10,000.00 | - | |
| Sep 18, 2020 | Glazer Capital, LLC69 | 10% Owner | Sell | 1,020 | $10.00 | $10,199.80 | - | |
| Sep 15, 2020 | Glazer Capital, LLC69 | 10% Owner | Sell | 1,482 | $9.99 | $14,805.18 | - | |
| Sep 8, 2020 | Glazer Capital, LLC69 | 10% Owner | Sell | 1 | $9.99 | $9.99 | - | |
| Aug 17, 2020 | Glazer Capital, LLC69 | 10% Owner | Sell | 3,398 | $9.99 | $33,946.02 | -0.2% |